In a combined multiple ascending dose and Phase IIa study in people with type 2 diabetes over 41 days, daily doses of cotadutide up to 200 g improved fasting and postprandial glucose levels and reduced body weight compared with placebo [79]
Constipation is common during early treatment and dose increases
Media Contact: Jamie Neider 8015205785 [email protected] Disclaimer: Pivot is not a medical provider and does not offer medical advice, diagnosis, or treatment
Ondansetron (Zofran), a prescription anti-nausea medication, is also safe and frequently prescribed alongside GLP-1 therapy, though it should be used short-term and under medical guidance to avoid masking dehydration or other warning signs
Neurological Disorders Emerging research indicates that L-Carnitine may have therapeutic potential in various neurological disorders
Daily dosing provides steady appetite regulation and eliminates concerns related to injections, making it a preferred option for individuals seeking a non-invasive approach